Psychological consequences and predictors of adverse events in the first 5 years after predictive testing for Huntington's disease

被引:91
作者
Almqvist, EW
Brinkman, RR
Wiggins, S
Hayden, MR
机构
[1] Univ British Columbia, Ctr Mol Med & Therapeut, Dept Med Genet, Vancouver, BC V5Z 4H4, Canada
[2] Karolinska Inst, Dept Nursing, Huddinge, Sweden
关键词
adverse events; genetic counselling; Huntington's disease; predictive testing; psychological distress;
D O I
10.1034/j.1399-0004.2003.00157.x
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The promise of genetic medicine is to provide information, based on genotype, to persons not yet sick about their risk of future illness. However, little is known of the long-term psychological effects for asymptomatic persons learning their risk of having a serious disease. Predictive genetic testing for Huntington's disease (HD) has been offered for the longest time for any disease. In the present study, the psychological consequences of predictive testing were assessed prospectively in individuals at risk for HD during seven visits over 5 years. Questionnaires of standard measures of psychological distress (the General Severity Index of the Symptom Check List-90-Revised), depression (the Beck Depression Inventory), and general well-being (the General Well-Being Scale) were administered to the participants. A significant reduction in psychological distress was observed for both result groups throughout 2 years (p < 0.001) and at 5 years (p = 0.002). Despite the overall improvement of the psychological well-being, 6.9% (14 of 202) of the participants experienced an adverse event during the first 2 years after predictive testing that was clinically significant. The frequency of all defined adverse events in the participants was 21.8%, with higher frequency in the increased risk group (p = 0.03) and most occurring within 12 months of receiving results.
引用
收藏
页码:300 / 309
页数:10
相关论文
共 43 条
[1]   Risk reversals in predictive testing for Huntington disease [J].
Almqvist, E ;
Adam, S ;
Bloch, M ;
Fuller, A ;
Welch, P ;
Eisenberg, D ;
Whelan, D ;
Macgregor, D ;
Meschino, W ;
Hayden, MR .
AMERICAN JOURNAL OF HUMAN GENETICS, 1997, 61 (04) :945-952
[2]   A worldwide assessment of the frequency of suicide, suicide attempts, or psychiatric hospitalization after predictive testing for Huntington disease [J].
Almqvist, EW ;
Bloch, M ;
Brinkman, R ;
Craufurd, D ;
Hayden, MR .
AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 64 (05) :1293-1304
[3]  
[Anonymous], 1989, J NEUROL SCI, V94, P327
[4]   AN INVENTORY FOR MEASURING DEPRESSION [J].
BECK, AT ;
ERBAUGH, J ;
WARD, CH ;
MOCK, J ;
MENDELSOHN, M .
ARCHIVES OF GENERAL PSYCHIATRY, 1961, 4 (06) :561-&
[5]   DIAGNOSIS OF HUNTINGTON DISEASE - A MODEL FOR THE STAGES OF PSYCHOLOGICAL RESPONSE BASED ON EXPERIENCE OF A PREDICTIVE TESTING PROGRAM [J].
BLOCH, M ;
ADAM, S ;
FULLER, A ;
KREMER, B ;
WELCH, JP ;
WIGGINS, S ;
WHYTE, P ;
HUGGINS, M ;
THEILMANN, J ;
HAYDEN, MR .
AMERICAN JOURNAL OF MEDICAL GENETICS, 1993, 47 (03) :368-374
[6]   PRESYMPTOMATIC DIAGNOSIS OF DELAYED-ONSET DISEASE WITH LINKED DNA MARKERS - THE EXPERIENCE IN HUNTINGTONS-DISEASE [J].
BRANDT, J ;
QUAID, KA ;
FOLSTEIN, SE ;
GARBER, P ;
MAESTRI, NE ;
ABBOTT, MH ;
SLAVNEY, PR ;
FRANZ, ML ;
KASCH, L ;
KAZAZIAN, HH .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1989, 261 (21) :3108-3114
[7]   PSYCHOLOGICAL COSTS AND BENEFITS OF PREDICTIVE TESTING FOR HUNTINGTONS-DISEASE [J].
CODORI, AM ;
BRANDT, J .
AMERICAN JOURNAL OF MEDICAL GENETICS, 1994, 54 (03) :174-184
[8]   SELF-SELECTION IN PREDICTIVE TESTING FOR HUNTINGTONS-DISEASE [J].
CODORI, AM ;
HANSON, R ;
BRANDT, J .
AMERICAN JOURNAL OF MEDICAL GENETICS, 1994, 54 (03) :167-173
[9]   Predictors of psychological adjustment to genetic testing for Huntington's disease [J].
Codori, AM ;
Slavney, PR ;
Young, C ;
Miglioretti, DL ;
Brandt, J .
HEALTH PSYCHOLOGY, 1997, 16 (01) :36-50
[10]  
CRAUFURD D, 1989, LANCET, V2, P603